P2Y14R antagonist 3 (compound A) is an orally active P2Y14R antagonist with an IC50 of 23.60 nM and a Kd of 7.26 µM. It mitigates lung injury in mice induced by Lipopolysaccharides (LPS) and can be utilized in the study of inflammatory diseases.
Molecular Weight:
487.51
Formula:
C26H25N5O5
Target:
P2Y Receptor
* VAT and and shipping costs not included. Errors and price changes excepted